Middletown, DE
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Leukemia Research Foundation of DE, founded in 2007, is a small nonprofit in the Medical Research sector that reported $396K in total revenue in fiscal year 2023. Revenue surged 168% from the prior year, signaling strong growth momentum. The organization ran a surplus of $393K, a strong 99% operating margin.
Funding for cancer research.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $395,844 | $147,841 | +1.7% |
| Expenses | $2,946 | $208,359 | -1.0% |
| Net Income | $392,898 | $-60,518 | -7.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Denni Ferrara | President | 10.00 |
Officer
|
$0 | $0 | $0 |
| Nicholas Ferrara | Secretary | 5.00 |
Officer
|
$0 | $0 | $0 |
| Don Yannick | Treasurer | 2.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $395,844 | $2,946 | $2,232,227 | $392,898 |
| 2023 | $147,841 | $208,359 | $1,839,329 | $-60,518 |
| 2022 | $114,296 | $57,070 | $1,899,847 | $57,226 |
| 2020 | $429,414 | $40,927 | $2,072,464 | $388,487 |
| 2019 | $438,152 | $526,900 | $1,683,977 | $-88,748 |
Compare Leukemia Research Foundation of DE with other nonprofits in Delaware and across the country.